Glycaemic control in patients with type 2 diabetes switching from premixed insulin to long-acting basal insulin analogue plus oral antidiabetic drugs: an observational study. (Q51309415)

From Wikidata

Jump to navigation Jump to search

scientific article published in October 2012

Language	Label	Description	Also known as
English	Glycaemic control in patients with type 2 diabetes switching from premixed insulin to long-acting basal insulin analogue plus oral antidiabetic drugs: an observational study.	scientific article published in October 2012

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22994330%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Glycaemic control in patients with type 2 diabetes switching from premixed insulin to long-acting basal insulin analogue plus oral antidiabetic drugs: an observational study (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22994330%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

type 2 diabetes

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Fernando Gomez-Peralta

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22994330%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

author name string

F Carramiñana-Barrera

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22994330%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

F J Félix-Redondo

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22994330%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

J Fraile-Gómez

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22994330%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Extreme Rescue Study Group

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22994330%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

publication date

1 October 2012

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22994330%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

International Journal of Clinical Practice

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22994330%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

66

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22994330%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22994330%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

959-968

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22994330%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.03000.X

21 January 2018

Beta-cell deterioration determines the onset and rate of progression of secondary dietary failure in type 2 diabetes mellitus: the 10-year follow-up of the Belfast Diet Study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.03000.X

21 January 2018

Standards of medical care in diabetes--2011.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.03000.X

21 January 2018

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.03000.X

21 January 2018

Systematic review: comparative effectiveness and safety of premixed insulin analogues in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.03000.X

21 January 2018

Three-year efficacy of complex insulin regimens in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.03000.X

21 January 2018

Glimepiride combined with morning insulin glargine, bedtime neutral protamine hagedorn insulin, or bedtime insulin glargine in patients with type 2 diabetes. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.03000.X

21 January 2018

Good glycemic control with flexibility in timing of basal insulin supply: a 24-week comparison of insulin glargine given once daily in the morning or at bedtime in combination with morning glimepiride

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.03000.X

21 January 2018

Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. HOE 901/3002 Study Group.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.03000.X

21 January 2018

A One-year, Randomised, Multicentre Trial Comparing Insulin Glargine with NPH Insulin in Combination with Oral Agents in Patients with Type 2 Diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.03000.X

21 January 2018

Therapy in type 2 diabetes: insulin glargine vs. NPH insulin both in combination with glimepiride.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.03000.X

21 January 2018

The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.03000.X

21 January 2018

Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.03000.X

21 January 2018

Safety and efficacy of insulin glargine (HOE 901) versus NPH insulin in combination with oral treatment in Type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.03000.X

21 January 2018

Comparison of once-daily insulin detemir with NPH insulin added to a regimen of oral antidiabetic drugs in poorly controlled type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.03000.X

21 January 2018

Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2012.03000.X

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51309415&oldid=1245437868"